Alimera Sciences

Developer of therapeutic solutions to treat diabetic macular edema (DME)

placeAlpharetta, Georgia, United States calendar_todayFounded 2003 groups79 employees language alimerasciences.com

Registered entities

Innovation

5 patent families (4 granted) — focus: Human necessities; filing pace slowing. Cited 430 times.

YearFilings
20121
20132
20141
20151
20161
20171
20181
20191
20212
20221

Investor mix

11 investors on record; lead investors include Polaris Partners, Intersouth Partners, Venrock, Domain Associates; 1 has since exited.

Investor typeCountShare
Venture capital764%
Private equity218%
Bank & private debt218%
Coming soon